Caxton Associates (New York)’s Coherent COHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$900K Sell
9,500
-18,000
-65% -$1.8M 0.03% 236
2024
Q3
$2.45M Sell
27,500
-79,500
-74% -$5.94M 0.09% 95
2024
Q2
$7.75M Buy
+107,000
New +$6.43M 0.27% 46
2023
Q3
Sell
-27,337
Closed -$1.39M 437
2023
Q2
$1.39M Buy
+27,337
New +$1.01M 0.21% 107
2022
Q4
Sell
-6,818
Closed -$238K 480
2022
Q3
$238K Buy
+6,818
New +$327K 0.03% 368
2017
Q4
Sell
-9,100
Closed -$374K 366
2017
Q3
$374K Buy
+9,100
New +$339K 0.01% 410

Other funds holding COHR

Caxton Associates (New York)'s COHR Position: Q4 2024 in Review

Caxton Associates (New York) reduced its Coherent (COHR) stake by 65% in Q4 2024, selling an estimated $1.8M and leaving 9,500 shares worth $900K. The position accounts for 0.03% of the portfolio, ranked #236.

Caxton Associates (New York) first reported a position in COHR in Q3 2017 and has held it in 6 quarters since. The position peaked at $7.75M in Q2 2024. 629 funds tracked by Wall St. Rank hold COHR as of Q4 2024.

  • Caxton Associates (New York) held 9,500 shares of Coherent worth $900K as of Q4 2024.
  • Caxton Associates (New York) sold 18,000 Coherent shares in Q4 2024, an estimated $1.8M.
  • Coherent made up 0.03% of Caxton Associates (New York)'s portfolio in Q4 2024, its #236 holding.
  • Caxton Associates (New York) first reported a position in Coherent in Q3 2017 and has held it in 6 quarters since.
  • Caxton Associates (New York)'s Coherent position peaked at $7.75M in Q2 2024.
  • 629 funds tracked by Wall St. Rank held Coherent as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.